Evidence map›Paper›PMID 39778977›Full record

SynthesisBMJ (Clinical research ed.)2025

Time to nursing home admission and death in people with dementia: systematic review and meta-analysis.

Chiara C Brück, Sanne S Mooldijk, Lieke M Kuiper, Muhammed L Sambou, Silvan Licher, Francesco Mattace-Raso, Frank J Wolters

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Predicting hospice eligibility among dementia patients using language models.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chiara C BrückDepartment of Public Health, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Sanne S MooldijkDepartment of Epidemiology, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Lieke M KuiperDepartment of Internal Medicine, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Muhammed L SambouDepartment of Epidemiology, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Silvan LicherDepartment of Epidemiology, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Francesco Mattace-RasoDepartment of Internal Medicine, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Frank J WoltersDepartment of Epidemiology, Erasmus MC University Medical Centre, Rotterdam, Netherlands f.j.wolters@erasmusmc.nl.ORCID 0000-0003-2226-4050

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo summarise available evidence on time to nursing home admission and death among people with dementia, and to explore prognostic indicators.

designSystematic review and meta-analysis. DATA SOURCES: Medline, Embase, Web of Science, Cochrane, and Google Scholar from inception to 4 July 2024. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Longitudinal studies on survival or nursing home admission in people with dementia. Studies with fewer than 150 participants, recruitment during acute hospital admission, or less than one year of follow-up were excluded.

results19 307 articles were identified and 261 eligible studies included. 235 reported on survival among 5 553 960 participants and 79 reported on nursing home admission among 352 990 participants. Median survival from diagnosis appeared to be strongly dependent on age, ranging from 8.9 years at mean age 60 for women to 2.2 years at mean age 85 for men. Women overall had shorter survival than men (mean difference 4.1 years (95% confidence interval 2.1 to 6.1)), which was attributable to later age at diagnosis in women. Median survival was 1.2 to 1.4 years longer in Asia than in the US and Europe, and 1.4 years longer for Alzheimer's disease compared with other types of dementia. Compared with studies before 2000, survival was longer in contemporary clinic based studies (P

conclusionsThe average life expectancy of people with dementia at time of diagnosis ranged from 5.7 years at age 65 to 2.2 at age 85 in men and from 8.0 to 4.5, respectively, in women. About one third of remaining life expectancy was lived in nursing homes, with more than half of people moving to a nursing home within five years after a dementia diagnosis. Prognosis after a dementia diagnosis is highly dependent on personal and clinical characteristics, offering potential for individualised prognostic information and care planning. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022341507.

Indexed as

DementiaNursing HomesAgedAged, 80 and overFemaleHumansMalePatient AdmissionPrognosisTime Factors

Identifiers

PMID39778977
PMCPMC11707802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.